ArticleACS omega2024
Machine Learning Approaches: Detecting the Disease Variants in Human-Exhaled Breath Biomarkers.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- MountPat: investigations on the EEG signals.Cognitive neurodynamics · 2026Article
- AI-driven breathomics for early detection of CFTR modulator resistance in cystic fibrosis.Annals of medicine and surgery (2012) · 2026Article
- Establishing T1 and ECV mapping based nomogram differentiate acute ischemic and nonischemic myocardial injury: a proof-of-concept study.BMC medical imaging · 2026Article
- Automated detection of Parkinson's disease using improved linknet-ghostnet model based on handwriting images.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent days, the development of sensor-based medical devices has been found to be very effective for the prediction and analysis of the onset of diseases. The instigation of an electronic nose (eNose) device is profound and very useful in diverse applications. The analysis of exhaled breath biomarkers using eNose sensors has attained wider attention among researchers, and the prediction of multiple disease variants using the same is still an open research problem. In this work, an enhanced XGBooster classifier-based prediction mechanism was introduced to identify the disease variants based on the responses of commercially available metal oxide-based Figaro (Japan) sensors including TGS826, TGS822, TGS2600, and TGS2602. The implemented model secured 98.36% prediction accuracy in multiclass disease prediction and classification. The homemade one-dimensional metal oxide sensing elements such as ZnO, Cr-doped ZnO, and ZnO/NiO were integrated with the aforementioned sensor array for the specific detection of the three biomarkers of interest. This model has attained a classification accuracy of 99.77, 94.91, and 96.56% toward ammonia, ethanol, and acetone, respectively. And the multiclass disease biomarker classification accuracy of the readymade and homemade eNose prototype models was compared, and the results are summarized.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.